{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:03:51Z","timestamp":1793833431678,"version":"4.6.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,12,7]],"date-time":"2006-12-07T00:00:00Z","timestamp":1165449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s10549-006-9438-y","type":"journal-article","created":{"date-parts":[[2006,12,6]],"date-time":"2006-12-06T09:45:25Z","timestamp":1165398325000},"page":"7-16","source":"Crossref","is-referenced-by-count":43,"title":["RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer"],"prefix":"10.1007","volume":"105","author":[{"given":"Y. S.","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Danks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sabokbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. A.","family":"Athanasou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,12,7]]},"reference":[{"key":"9438_CR1","first-page":"1","volume-title":"Bone metastases: monitoring and treatment","author":"BA Stoll","year":"1983","unstructured":"Stoll BA (1983) Natural history, prognosis and staging of bone metastases. In: Stoll BA, Parbhoo S (eds) Bone metastases: monitoring and treatment. Raven Press, New York, pp 1\u20134"},{"key":"9438_CR2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/jor.1100140309","volume":"14","author":"DR Clohisy","year":"1996","unstructured":"Clohisy DR, Palkert D, Ramnaraine ML, Pekurovsky I, Oursler MJ (1996) Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis. J Orthop Res 14:396\u2013402","journal-title":"J Orthop Res"},{"key":"9438_CR3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/8756-3282(91)90057-P","volume":"12","author":"GR Mundy","year":"1991","unstructured":"Mundy GR (1991) Mechanisms of osteolytic bone destruction. Bone 12:51\u201356","journal-title":"Bone"},{"key":"9438_CR4","first-page":"189","volume":"19","author":"HC Blair","year":"2004","unstructured":"Blair HC, Athanasou NA (2004) Recent advances in osteoclast biology. Histol and Histopathol 19:189\u2013199","journal-title":"Histol and Histopathol"},{"key":"9438_CR5","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1210\/endo.137.9.8756585","volume":"137","author":"Y Fujikawa","year":"1996","unstructured":"Fujikawa Y, Quinn JM, Sabokbar A, McGee JO, Athanasou NA (1996) The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137:4058\u20134060","journal-title":"Endocrinology"},{"key":"9438_CR6","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclast inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA 95:3597\u20133602","journal-title":"Proc Natl Acad Sci USA"},{"key":"9438_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"LC Hofbauer","year":"2000","unstructured":"Hofbauer LC, Khosla S, Dunstan C, Lacey DL, Boyle W, Riggs BL (2000) The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. Bone Min Res 15:2\u201312","journal-title":"Bone Min Res"},{"key":"9438_CR8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ, et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"9438_CR9","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1210\/endo.140.10.7037","volume":"140","author":"RJ Thomas","year":"1999","unstructured":"Thomas RJ, Guise TA, Yin JJ, Elliott J, Horwood NJ, Martin TJ, Gillespie MT (1999) Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140:4451\u20134458","journal-title":"Endocrinology"},{"key":"9438_CR10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bone.2003.08.008","volume":"34","author":"I Itonaga","year":"2004","unstructured":"Itonaga I, Kudo O, Sabokbar A, Danks L, Ferguson D, Fujikawa Y, Athanasou NA (2004) Transforming growth factor \u03b2 induces human osteoclast formation. Bone 34:57\u201364","journal-title":"Bone"},{"key":"9438_CR11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. J Exp Med 191:275\u2013286","journal-title":"J Exp Med"},{"key":"9438_CR12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/path.1190","volume":"198","author":"O Kudo","year":"2002","unstructured":"Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T, Athanasou NA (2002) Proinflammatory cytokine (TNFalpha\/IL-1alpha) induction of human osteoclast formation. J Pathol 198:220\u2013227","journal-title":"J Pathol"},{"key":"9438_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(02)00915-8","volume":"32","author":"O Kudo","year":"2003","unstructured":"Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA (2003) Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32:1\u20137","journal-title":"Bone"},{"key":"9438_CR14","first-page":"4141","volume":"47","author":"PJ Bugelski","year":"1987","unstructured":"Bugelski PJ, Corwin SP, North SM, Kirsh RL, Nicolson GL, Poste G (1987) Macrophage content of spontaneous metastases at different stages of growth. Cancer Res 47:4141\u20134145","journal-title":"Cancer Res"},{"key":"9438_CR15","first-page":"166","volume":"67","author":"HH Ravenswaay Classen Van","year":"1992","unstructured":"Van Ravenswaay Classen HH, Kluin PM, Fleuren G (1992) Tumour infiltrating cells in human cancer: on the possible role of CD16+ macrophages in anti-tumour cytoxicity. Lab Invest 67:166\u2013174","journal-title":"Lab Invest"},{"key":"9438_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1242\/jcs.101.3.681","volume":"101","author":"JM Quinn","year":"1992","unstructured":"Quinn JM, Athanasou NA, McGee JO\u2019D (1992) Tumour infiltrating macrophages are capable of bone resorption. J Cell Science 101:681\u2013686","journal-title":"J Cell Science"},{"key":"9438_CR17","first-page":"465","volume":"71","author":"J Quinn","year":"1994","unstructured":"Quinn J, Matsumura Y, Tarin D, McGee JO\u2019D, Athanasou NA (1994) Cellular and hormonal mechanisms associated with malignant bone resorption. Lab Invest 71:465\u2013471","journal-title":"Lab Invest"},{"key":"9438_CR18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1054\/bjoc.2001.1856","volume":"85","author":"N Hunt","year":"2001","unstructured":"Hunt N, Fujikawa Y, Itonaga I, Harris A, Athanasou NA (2001) Cellular mechanisms of bone resorption in breast cancer. Br J Cancer 85:78\u201384","journal-title":"Br J Cancer"},{"key":"9438_CR19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-9896(199801)184:1<31::AID-PATH962>3.0.CO;2-V","volume":"184","author":"JMW Quinn","year":"1998","unstructured":"Quinn JMW, McGee JO\u2019D, Athanasou NA (1998) Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells. J Pathol 184:31\u201336","journal-title":"J Pathol"},{"key":"9438_CR20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/jcp.43.12.997","volume":"43","author":"NA Athanasou","year":"1990","unstructured":"Athanasou NA, Quinn J (1990) Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol 43:997\u20131003","journal-title":"J Clin Pathol"},{"key":"9438_CR21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02411252","volume":"34","author":"C Minkin","year":"1982","unstructured":"Minkin C (1982) Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34:285\u2013290","journal-title":"Calcif Tissue Int"},{"key":"9438_CR22","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1083\/jcb.109.4.1817","volume":"109","author":"J Davies","year":"1989","unstructured":"Davies J, Warwick J, Totty N, Philp R, Helfrich M, Horton M (1989) The osteoclast functional antigen, implicated in the regulation of bone resorption, is biochemically related to the vitronectin receptor. J Cell Biol 109:1817\u20131826","journal-title":"J Cell Biol"},{"key":"9438_CR23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF03354640","volume":"56","author":"R Gundle","year":"1995","unstructured":"Gundle R, Beresford JN (1995) The isolation and culture of cells from explants of human trabecular bone. Calcif Tissue Int 56:8\u201310","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"9438_CR24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/path.1953","volume":"209","author":"SG Sun","year":"2006","unstructured":"Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA (2006) Bone stromal cells in pagetic bone and Paget\u2019s sarcoma express RANKL and support human osteoclast formation. J Pathol 209(1):114\u2013120","journal-title":"J Pathol"},{"key":"9438_CR25","first-page":"419","volume":"118","author":"PJ Bugelski","year":"1985","unstructured":"Bugelski PJ, Kirsh RL, Sowinski JM, Poste GL (1985) Changes in the macrophage content of lung metastases at different stages in tumor growth. Am J Pathol 118:419\u2013424","journal-title":"Am J Pathol"},{"key":"9438_CR26","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00048093","volume":"4","author":"SJ Normann","year":"1985","unstructured":"Normann SJ (1985) Macrophage infiltration and tumour progression. Cancer Metastasis Rev 4:227\u2013291","journal-title":"Cancer Metastasis Rev"},{"key":"9438_CR27","first-page":"726","volume":"276","author":"CBS Galasko","year":"1976","unstructured":"Galasko CBS (1976) Mechanisms of bone destruction in the development of skeletal metastasis. Nature 276:726\u2013728","journal-title":"Nature"},{"key":"9438_CR28","first-page":"5","volume":"71","author":"A Mantovani","year":"1994","unstructured":"Mantovani A (1994) Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab Invest 71:5\u201316","journal-title":"Lab Invest"},{"key":"9438_CR29","first-page":"856","volume":"145","author":"S Yamashiro","year":"1994","unstructured":"Yamashiro S, Takaya M, Nishi T, Kuratsu J, Yashimura T, Usho Y, Takahashi K (1994) Tumor-derived monocyte chemoattractant protein induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumour. Am J Pathol 145:856\u2013867","journal-title":"Am J Pathol"},{"key":"9438_CR30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0006-291X(91)91445-I","volume":"174","author":"T Yoshimura","year":"1991","unstructured":"Yoshimura T, Takeya M, Takahashi K (1991) Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumour cell lines. Biochem Biophys Res Commun 174:504\u2013509","journal-title":"Biochem Biophys Res Commun"},{"key":"9438_CR31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00062752-199805000-00006","volume":"5","author":"AM Flanagan","year":"1998","unstructured":"Flanagan AM, Lader CS (1998) Update on the biologic effects of macrophage-colony stimulating factor. Curr Opinion Hematol 5:181\u2013185","journal-title":"Curr Opinion Hematol"},{"key":"9438_CR32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A","volume":"72","author":"J Faust","year":"1999","unstructured":"Faust J, Lacey DL, Hunt P, Burgess TL, Scully S, Van G, Eli A, Qian Y, Shalhoub V (1999) Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors. J Cell Biochem 72:67\u201380","journal-title":"J Cell Biochem"},{"key":"9438_CR33","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1210\/endo.139.10.6331","volume":"139","author":"JWM Quinn","year":"1998","unstructured":"Quinn JWM, Elliott J, Gillespie MT, Martin TJ (1998) A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation. Endocrinology 139:4424\u20134427","journal-title":"Endocrinology"},{"key":"9438_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.1999.01491.x","volume":"106","author":"HM Massey","year":"1999","unstructured":"Massey HM, Flanagan AM (1999) Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 106:167\u2013170","journal-title":"Br J Haematol"},{"key":"9438_CR35","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1359\/jbmr.2000.15.8.1459","volume":"15","author":"JM Quinn","year":"2000","unstructured":"Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ (2000) Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 15:1459\u20131466","journal-title":"J Bone Miner Res"},{"key":"9438_CR36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.orthres.2004.10.006","volume":"23","author":"A Sabokbar","year":"2005","unstructured":"Sabokbar A, Itonaga I, Sun SG, Kudo O, Athanasou NA (2005) Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. J Orthop Res 23:511\u2013519","journal-title":"J Orthop Res"},{"key":"9438_CR37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","volume":"43","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S (2000) Involvement of receptor activator of nuclear factor kappaB ligand\/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 43:259\u2013269","journal-title":"Arthritis Rheum"},{"key":"9438_CR38","doi-asserted-by":"crossref","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","volume":"273","author":"JG Emery","year":"1998","unstructured":"Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, Diprinzio R, Dodds RA, James IE, Rosenberg M, Lee JC, Young PR (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem 273:14363\u201314367","journal-title":"J Biol Chem"},{"key":"9438_CR39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jcp.2005.026534","volume":"59","author":"C Poznak Van","year":"2006","unstructured":"Van Poznak C, Cross SS, Saggese M, Hudis C, Panageas KS, Norton L, Coleman RE, Holen I (2006) Espression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours. J Clin Pathol 59:56\u201363","journal-title":"J Clin Pathol"},{"key":"9438_CR40","first-page":"5849","volume":"59","author":"L Pederson","year":"1999","unstructured":"Pederson L, Winding B, Foged NT (1999) Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity. Cancer Res 59:5849\u20135855","journal-title":"Cancer Res"},{"key":"9438_CR41","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/sj.bjc.6603103","volume":"94","author":"YS Lau","year":"2006","unstructured":"Lau YS, Sabokbar A, Giele H, Cerundolo V, Hofstetter W, Athanasou NA (2006) Malignant melanoma and bone resorption. Br J Cancer 94:1496\u2013503","journal-title":"Br J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9438-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-006-9438-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-006-9438-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T13:32:23Z","timestamp":1628170343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-006-9438-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["9438"],"URL":"https:\/\/doi.org\/10.1007\/s10549-006-9438-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,7]]}}}